Literature DB >> 21471342

Practical disk-based method for detection of Escherichia coli clinical isolates producing the fluoroquinolone-modifying enzyme AAC(6')-Ib-cr.

Jun-Ichi Wachino, Kunikazu Yamane, Yoshichika Arakawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21471342      PMCID： PMC3122779          DOI： 10.1128/JCM.00278-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  7 in total

1.  Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme.

Authors:  Chi Hye Park; Ari Robicsek; George A Jacoby; Daniel Sahm; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

2.  Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.

Authors:  Ari Robicsek; Jacob Strahilevitz; George A Jacoby; Mark Macielag; Darren Abbanat; Chi Hye Park; Karen Bush; David C Hooper
Journal:  Nat Med       Date:  2005-12-20       Impact factor: 53.440

3.  aac(6')-Ib-cr genotyping by simultaneous high-resolution melting analyses of an unlabeled probe and full-length amplicon.

Authors:  Jan M Bell; John D Turnidge; Patiyan Andersson
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

4.  Rapid detection of aac(6')-Ib-cr quinolone resistance gene by pyrosequencing.

Authors:  Thomas Guillard; Véronique Duval; Hélène Moret; Lucien Brasme; Véronique Vernet-Garnier; Christophe de Champs
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

5.  Detection of plasmid-mediated quinolone resistance genes in clinical isolates of Enterobacter spp. in Spain.

Authors:  M E Cano; J M Rodríguez-Martínez; J Agüero; A Pascual; J Calvo; J M García-Lobo; C Velasco; M V Francia; L Martínez-Martínez
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

Review 6.  Plasmid-mediated quinolone resistance: a multifaceted threat.

Authors:  Jacob Strahilevitz; George A Jacoby; David C Hooper; Ari Robicsek
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

7.  Acetylation of fluoroquinolone antimicrobial agents by an Escherichia coli strain isolated from a municipal wastewater treatment plant.

Authors:  C M Jung; T M Heinze; R Strakosha; C A Elkins; J B Sutherland
Journal:  J Appl Microbiol       Date:  2009-02       Impact factor: 3.772
  7 in total
  4 in total

1.  Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.

Authors:  T Guillard; E Cambau; F Chau; L Massias; C de Champs; B Fantin
Journal:  Antimicrob Agents Chemother       Date:  2013-09-09       Impact factor: 5.191

2.  Rapid detection of AAC(6')-Ib-cr production using a MALDI-TOF MS strategy.

Authors:  C-A Pardo; R N Tan; C Hennequin; R Beyrouthy; R Bonnet; F Robin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-24       Impact factor: 3.267

3.  Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131.

Authors:  Minh-Duy Phan; Kate M Peters; Laura Alvarez Fraga; Steven C Wallis; Steven J Hancock; Nguyen Thi Khanh Nhu; Brian M Forde; Michelle J Bauer; David L Paterson; Scott A Beatson; Jeffrey Lipman; Mark A Schembri
Journal:  Antimicrob Agents Chemother       Date:  2021-11-15       Impact factor: 5.938

4.  Detection of aac(6')-Ib-cr in avian pathogenic Escherichia coli isolates in Japan.

Authors:  Michiko Kawanishi; Manao Ozawa; Mototaka Hiki; Hitoshi Abo; Akemi Kojima; Tetsuo Asai
Journal:  J Vet Med Sci       Date:  2013-07-12       Impact factor: 1.267
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.